Detalhe da pesquisa
1.
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.
Blood
; 136(26): 3041-3050, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367545
2.
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group.
Blood
; 134(19): 1608-1618, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31554635
3.
Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
Eur J Haematol
; 100(2): 154-162, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29114972
4.
Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment.
Blood
; 126(24): 2578-84, 2015 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26480933
5.
Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation.
Blood
; 124(23): 3441-9, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25270908
6.
Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.
Blood
; 123(26): 4027-36, 2014 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24797300
7.
Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy.
Haematologica
; 101(7): 839-45, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27036160
8.
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study.
Ann Hematol
; 95(12): 1931-1942, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27696203
9.
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 16(1): 57-66, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25524800
10.
ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group.
Haematologica
; 100(3): 324-30, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596267
11.
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.
Blood
; 119(2): 551-8, 2012 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22096250
12.
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.
Blood
; 120(26): 5185-7, 2012 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23024237
13.
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.
Blood
; 117(7): 2137-45, 2011 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21127174
14.
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.
Ann Hematol
; 92(1): 41-52, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23090499
15.
Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia.
Haematologica
; 102(4): e132-e135, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28082340
16.
Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.
Cancers (Basel)
; 13(22)2021 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830762
17.
Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study.
J Clin Oncol
; 38(6): 623-632, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851556
18.
First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.
Transfusion
; 49(9): 1836-44, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19453990
19.
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.
Leukemia
; 32(7): 1621-1630, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720733
20.
Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).
AIDS
; 16(11): 1479-87, 2002 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-12131185